Synapsoft logo
AI Insights from Disclosures
Searching...
YUHAN CORPORATION 000100
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
YUHAN CORPORATION's main business purpose is the manufacture and sale of pharmaceuticals, chemicals, industrial chemicals, veterinary drugs, and household products, with major products including 'Leclaza', 'Antiphlamine', 'Ppikomssi', 'Duowell', and 'Copu Syrup'. In the first half of its 102nd fiscal year, the business environment remained difficult amid unprecedented uncertainty from the Israel-Hamas war, the Ukraine-Russia war, US-China tensions, and global inflation, but with the enthusiastic support of shareholders, all executives and employees united around the management indicators of 'Passion', 'Proactive', and 'Perseverance' and did their utmost, achieving growth of 3.6% year on year.
Representative Director 대표이사 조욱제
Founded June 20, 1926
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-0014409
Business number 118-81-00601
Phone Number 02-828-0181
Fax Number 02-828-0117
Website www.yuhan.co.kr
Company Address 74 Noryangjin-ro, Dongjak-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant